Approximately 9% of the United States population will develop a kidney stone in their lifetime. Lifestyle factors, genetics, and diet all contribute to the development of kidney stones. The most common type of kidney stone is comprised of calcium oxalate (CaOx) crystals. Research on kidney stones is hampered by limited access to kidney cells and tissue from patients. Very few studies have focused on circulating immune cells which may play a role in disease processes. Monocytes/macrophages are essential for crystal clearance and are recruited to the renal interstitium. We recently determined that monocytes but not lymphocytes or platelets have lower mitochondrial function in patients with CaOx kidney stones compared to healthy subjects. The objective of the current proposal is to evaluate for changes in mitochondrial function, oxidative stress, and inflammatory responses in circulating monocytes and plasma from a large cohort of patients with CaOx kidney stones and healthy subjects. This may identify specific responses associated with this disease. The central hypothesis of the current proposal is circulating monocytes in patients with CaOx kidney stones develop mitochondrial dysfunction due to cellular events mediated by CaOx stones and/or exposure to CaOx crystals in the nephron. This hypothesis will be tested by pursuing three specific aims: 1) Determine whether mitochondrial dysfunction, oxidative stress, and inflammation are associated with circulating monocyte subtypes in patients with CaOx kidney stones; 2) Elucidate whether cytokines or CaOx crystals induce NLRP3 inflammasome pathways and mitochondrial dysfunction in primary monocytes and a human derived monocyte cell line; and 3) Determine whether a dietary oxalate load that produces urinary CaOx crystals in healthy subjects causes similar monocyte responses to those observed in patients. The proposed studies may provide new insights regarding the role of monocyte function and inflammation in CaOx kidney stone disease. This research plan will allow the applicant to gain additional experience in kidney stone disease and clinical research plus training in mass spectrometry, renal pathophysiology, immunology, and biostatistics through practical experience, course work, and guidance from an experienced mentoring team. It will also advance and facilitate the success of the applicant to transition into becoming an independent and productive NIH-funded investigator focused on monocytes and kidney stone disease.

Public Health Relevance

The goal of this proposal is to determine the significance of mitochondrial function in circulating monocytes in patients with calcium oxalate (CaOx) kidney stone disease. Successful completion of the study will provide insight regarding monocytes and inflammation in CaOx kidney stone disease and may lead to strategies to intervene in the pathogenesis and prognosis of the disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Scientist Development Award - Research & Training (K01)
Project #
5K01DK106284-03
Application #
9513535
Study Section
Kidney, Urologic and Hematologic Diseases D Subcommittee (DDK)
Program Officer
Rankin, Tracy L
Project Start
2016-09-15
Project End
2021-06-30
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
3
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Urology
Type
Schools of Medicine
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Mitchell, Tanecia (2018) Stay in the Loop: New Insights about Randall's Plaques and Stone Disease. Am J Physiol Renal Physiol :
Patel, Mikita; Yarlagadda, Vidhush; Adedoyin, Oreoluwa et al. (2018) Oxalate induces mitochondrial dysfunction and disrupts redox homeostasis in a human monocyte derived cell line. Redox Biol 15:207-215